Interaction of complement with HIV-1 and Candida albicans: molecular mechanisms and biological implications

Affiliations

Review

M P Dierich et al. Mol Immunol. 1990 Dec.

. 1990 Dec;27(12):1349-53.

doi: 10.1016/0161-5890(90)90042-x.

No abstract available

Similar articles

Complement in Candida albicans infections.
Rambach G, Speth C. Rambach G, et al. Front Biosci (Elite Ed). 2009 Jun 1;1(1):1-12. doi: 10.2741/E1. Front Biosci (Elite Ed). 2009. PMID: 19482619 Review.
A role for complement receptor-like molecules in iron acquisition by Candida albicans.
Moors MA, Stull TL, Blank KJ, Buckley HR, Mosser DM. Moors MA, et al. J Exp Med. 1992 Jun 1;175(6):1643-51. doi: 10.1084/jem.175.6.1643. J Exp Med. 1992. PMID: 1588285 Free PMC article.
Activation of the alternative (properdin) pathway of complement by Candida albicans and related species.
Ray TL, Wuepper KD. Ray TL, et al. J Invest Dermatol. 1976 Dec;67(6):700-3. doi: 10.1111/1523-1747.ep12598581. J Invest Dermatol. 1976. PMID: 794419
Membrane attack complex formation on yeast as trigger of selective release of terminal complement proteins from human polymorphonuclear leukocytes.
Lukasser-Vogl E, Gruber A, Lass-Flörl C, Eder A, Høgåsen AK, Morgan BP, Dierich MP, Würzner R. Lukasser-Vogl E, et al. FEMS Immunol Med Microbiol. 2000 May;28(1):15-23. doi: 10.1111/j.1574-695X.2000.tb01452.x. FEMS Immunol Med Microbiol. 2000. PMID: 10767603
[Recent trends in complement research].
Inai S. Inai S. Nihon Rinsho. 1983;41(4):750-5. Nihon Rinsho. 1983. PMID: 6350645 Review. Japanese. No abstract available.

Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41.
Ebenbichler CF, Thielens NM, Vornhagen R, Marschang P, Arlaud GJ, Dierich MP. Ebenbichler CF, et al. J Exp Med. 1991 Dec 1;174(6):1417-24. doi: 10.1084/jem.174.6.1417. J Exp Med. 1991. PMID: 1744579 Free PMC article.